Zdrowie i gospodarka · 09/02/2006

FDA Proposes Reclassification of Intervertebral Body Fusion Devices

The FDA is proposing to reclassify intervertebral body fusion devices that contain bone grafting material from class III to class II, while retaining those with therapeutic biologics, based on the recommendation of the Orthopaedic and Rehabilitation Devices Panel.